Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Newly-diagnosed diabetes and admission hyperglycemia are linked to rapid respiratory deterioration in COVID-19 patients.
Read More »COVID-19 Severity Perceived in Recently Diagnosed Diabetes Patients
Optimal Treatment In T2D For CV Protection
How triple therapy can lead to optimal cardiovascular and renal protection.
Read More »Weekly Semaglutide vs. Daily Sitagliptin in T2D Patients
One diabetes drug showed superior results for A1C reduction and weight loss.
Read More »Bone Density Mass in Youth with Type 2 Diabetes
What is the impact of type 2 diabetes on bone formation in maturing bodies?
Read More »Telemedicine For Management of Diabetes Amid COVID-19 Concerns: Does It Work?
Patients are relieved to know that care continues through the coronavirus pandemic.
Read More »Unique Shake Improves Glycemic Control in T2D
A clinical pilot study reveals a new way to improve glycemic control by replacing daily breakfast and afternoon snacks with a diabetes-specific nutritional shake.
Read More »Early Metabolic Features In Relation to Type 2 Diabetes Susceptibility
The likelihood of developing type 2 diabetes can be detected at an early age.
Read More »Should Screening for Type 2 Diabetes Be More Aggressive?
Earlier diagnosis and treatment prevent complications.
Read More »T2DM Medications: All-Star Team Lineup
A recently published meta-analysis puts metformin to the test to see how well it lines up against other T2DM “Medication All-Star Team” members.
Read More »Empagliflozin Outcome on Obstructive Sleep Apnea, Cardiovascular, and Renal Events
The unique benefits of using empagliflozin need to be considered when determining treatments for type 2 patients.
Read More »